Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.

MLA

Bernardini, Federico, et al. “Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.” Pharmaceutics, vol. 15, no. 7, July 2023. EBSCOhost, https://doi.org/10.3390/pharmaceutics15071858.

APA

Bernardini, F., Nusca, A., Coletti, F., La Porta, Y., Piscione, M., Vespasiano, F., Mangiacapra, F., Ricottini, E., Melfi, R., Cavallari, I., Ussia, G. P., & Grigioni, F. (2023). Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease. Pharmaceutics, 15(7). https://doi.org/10.3390/pharmaceutics15071858

Chicago

Bernardini, Federico, Annunziata Nusca, Federica Coletti, Ylenia La Porta, Mariagrazia Piscione, Francesca Vespasiano, Fabio Mangiacapra, et al. 2023. “Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.” Pharmaceutics 15 (7). doi:10.3390/pharmaceutics15071858.